|
MTCH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28579999999035E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83405999999442E-05 |
| Normal-vs-Stage2 |
2.164600E-01 |
| Normal-vs-Stage3 |
3.059000E-01 |
| Normal-vs-Stage4 |
1.035010E-01 |
| Stage1-vs-Stage2 |
6.419600E-01 |
| Stage1-vs-Stage3 |
5.540600E-01 |
| Stage1-vs-Stage4 |
6.827000E-01 |
| Stage2-vs-Stage3 |
8.815000E-01 |
| Stage2-vs-Stage4 |
5.897800E-01 |
| Stage3-vs-Stage4 |
5.440000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8294999999946E-05 |
| Normal-vs-AfricanAmerican |
2.095400E-01 |
| Normal-vs-Asian |
1.103750E-01 |
| Caucasian-vs-AfricanAmerican |
1.633840E-01 |
| Caucasian-vs-Asian |
3.175400E-01 |
| AfricanAmerican-vs-Asian |
1.887050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05129999997222E-06 |
| Normal-vs-Female |
1.405820E-01 |
| Male-vs-Female |
2.701000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.559600E-03 |
| Normal-vs-Extreme_Weight |
1.084990E-03 |
| Normal-vs-Obese |
4.394100E-02 |
| Normal-vs-Extreme_Obese |
3.705400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.537800E-01 |
| Normal_Weight-vs-Obese |
2.844800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.138600E-01 |
| Extreme_Weight-vs-Obese |
3.542200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.814200E-01 |
| Obese-vs-Extreme_Obese |
9.279400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.996800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.868200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.36340000014934E-07 |
| Normal-vs-Age(81-100Yrs) |
1.948220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.097000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.913900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.749800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.073600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.779200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.088420E-02 |
| Normal-VS-Type2 PRCC |
1.459420E-03 |
| Normal-VS-KIRP CIMP |
3.741200E-01 |
| Normal-VS-Unclassified PRCC |
7.260000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.984400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.022000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.997020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.271200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.530000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.988000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04850000004486E-06 |
| Normal-vs-N1 |
4.147000E-01 |
| Normal-vs-N2 |
3.83499999978554E-07 |
| N0-vs-N1 |
1.168420E-01 |
| N0-vs-N2 |
2.293800E-01 |
| N1-vs-N2 |
1.494620E-01 |
|
|
